Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the priority given to members of the public with severe allergic conditions under the covid-19 vaccination programme.

The Joint Committee on Vaccination and Immunisation’s (JCVI) advice on priority groups for COVID-19 vaccination is based on a range of evidence and assessments, including a review of UK epidemiological data on the impact of the COVID-19 pandemic so far and data on demographic and clinical risk factors for mortality and hospitalisation from COVID-19. To date, having severe allergic conditions alone has not been identified as a condition that would place an individual at increased clinical risk to COVID-19.